However, since our negative control mimic did not induce NED even in serum-reduced conditions, we suggest a novel mechanism of NED in prostate cancer that is initiated by miR-652 expression through inhibition of PP2A in LNCaP cells. The gene discussed is PTPA; the disease is prostate carcinoma.